Financials
Financial year 2025
LE ROEULX MED from Le Roeulx, company number BE0478087264, closed financial year 2025 with a result of € 144,101 after tax. For that financial year LE ROEULX MED recorded a gross margin of € 243,045 and equity of € 860,581. Compared with financial year 2024, the result moved from € 145,486 to € 144,101. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 13, 2026.
€ 860,581
▲ 6% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 144,101
▼ 1% vs 2024
Profit after tax over the fiscal year.
€ 14,237
▼ 51% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 99,000 paid out
69 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 28,479
▲ 2% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 87,572
▲ € 81,413 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 16,945
Loans from banks and other lenders, long and short.
€ 2,421
▲ 69% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 17,949
▼ 30% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 228,092 | € 246,596 | € 259,287 | € 243,045 | ▼ 6% |
| Profit after taxes | € 116,066 | € 131,301 | € 145,486 | € 144,101 | ▼ 1% |
| Equity | € 721,693 | € 775,994 | € 815,480 | € 860,581 | ▲ 6% |
| Total debts | € 39,516 | € 48,307 | € 59,596 | € 81,561 | ▲ 37% |
| Cash | € 28,083 | € 29,163 | € 28,880 | € 14,237 | ▼ 51% |
| Land & buildings | € 144,439 | € 160,056 | € 150,117 | € 142,111 | ▼ 5% |
| Retained profit | € 709,293 | € 763,594 | € 803,080 | € 848,181 | ▲ 6% |
| Dividend | € 95,000 | € 77,000 | € 106,000 | € 99,000 | ▼ 7% |
| Bank debt | € 16,815 | € 16,992 | € 17,000 | € 16,945 | |
| Balance sheet total | € 761,210 | € 824,301 | € 875,075 | € 942,142 | ▲ 8% |
Key figures of LE ROEULX MED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to LE ROEULX MED?
What happened at LE ROEULX MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 144,101 (▼ 1% vs 2024). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Le Roeulx. KBO
In short
From € 116,066 profit in 2022 to € 144,101 profit in 2025.
Paid € 234,862 in corporate taxes since 2022.
Best year ever: 2024, with € 145,486 profit.
Paid out € 377,000 in dividends to the owners in total.
Management
Behind LE ROEULX MED are Yasmine Henriet and Jean Cerny.
Directors
According to the 2025 annual accounts
Yasmine Henriet
Director
Jean Cerny
Director
Establishments
Establishment units
Physical locations of this company
Rue de la Station(R) 92
7070 Le Roeulx
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0478.087.264
- VAT number
- BE 0478.087.264
- Registered office
- Rue de la Station(R) 92, 7070 Le Roeulx
- Names & denominations
- LE ROEULX MED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 July 2002
- Peppol
- Active · Active since 11 Dec 2025
- Contact
- [email protected] 064/26.78.90
- Activities · NACE
Activiteiten van medisch specialisten
Medische praktijken